These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23461505)

  • 1. [Letter to the editor].
    Román González N; Quintana Holgado A; Himénez Hernández MP
    Farm Hosp; 2013; 37(1):75-6. PubMed ID: 23461505
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparative study of paliperidone palmitate and risperidone long-acting injectable therapy in schizophrenia.
    Li H; Rui Q; Ning X; Xu H; Gu N
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1002-8. PubMed ID: 21315787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paliperidone palmitate versus oral risperidone and risperidone long-acting injection in patients with recently diagnosed schizophrenia: a tolerability and efficacy comparison.
    Fu DJ; Bossie CA; Sliwa JK; Ma YW; Alphs L
    Int Clin Psychopharmacol; 2014 Jan; 29(1):45-55. PubMed ID: 24113628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding Therapy With Long-Acting Antipsychotic Medication in Patients With Schizophrenia.
    Carpenter WT; Buchanan RW
    JAMA Psychiatry; 2015 Aug; 72(8):745-6. PubMed ID: 26107157
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical pharmacology of paliperidone palmitate a parenteral long-acting formulation for the treatment of schizophrenia.
    Gilday E; Nasrallah HA
    Rev Recent Clin Trials; 2012 Feb; 7(1):2-9. PubMed ID: 22023179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paliperidone palmitate for schizophrenia.
    Nussbaum AM; Stroup TS
    Schizophr Bull; 2012 Nov; 38(6):1124-7. PubMed ID: 22966147
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost effectiveness of paliperidone palmitate for the treatment of schizophrenia in Germany.
    Zeidler J; Mahlich J; Greiner W; Heres S
    Appl Health Econ Health Policy; 2013 Oct; 11(5):509-21. PubMed ID: 23975630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind study of paliperidone palmitate and risperidone long-acting injectable in adults with schizophrenia.
    Pandina G; Lane R; Gopal S; Gassmann-Mayer C; Hough D; Remmerie B; Simpson G
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):218-26. PubMed ID: 21092748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risperidone for chronic schizophrenia.
    Med Lett Drugs Ther; 1994 Apr; 36(920):33-4. PubMed ID: 7511777
    [No Abstract]   [Full Text] [Related]  

  • 10. Paliperidone palmitate for refractory and clozapine-resistant schizophrenia.
    Maia-de-Oliveira JP; Nunes EA; Ushirohira JM; Machado-de-Sousa JP; Bressan RA; Hallak JE
    J Neuropsychiatry Clin Neurosci; 2015; 27(1):e14-6. PubMed ID: 25716490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of an economic model of paliperidone palmitate for chronic schizophrenia.
    Einarson TR; Hemels ME
    J Med Econ; 2013 Nov; 16(11):1267-74. PubMed ID: 24003857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic medication in the treatment of schizophrenia.
    Kane JM
    Isr J Psychiatry Relat Sci; 1995; 32(1):30-7. PubMed ID: 7542642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical review of risperidone.
    Chouinard G; Arnott W
    Can J Psychiatry; 1993 Sep; 38 Suppl 3():S89-95. PubMed ID: 7504574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expected clinical benefits of paliperidone extended-release formulation when compared with risperidone immediate-release.
    Pani L; Marchese G
    Expert Opin Drug Deliv; 2009 Mar; 6(3):319-31. PubMed ID: 19317589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-year treatment continuation in patients switched to paliperidone palmitate: a retrospective study.
    Hamer J; Norman TR; Kanaan RA
    J Clin Psychiatry; 2014 Nov; 75(11):1267-9. PubMed ID: 25470090
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment options for residual insomnia in schizophrenia.
    Baandrup L; Jennum P; Lublin H; Glenthoj B
    Acta Psychiatr Scand; 2013 Jan; 127(1):81-2. PubMed ID: 23106614
    [No Abstract]   [Full Text] [Related]  

  • 17. What are the nursing implications when using paliperidone prolonged release for people with schizophrenia.
    Jones A
    J Psychiatr Ment Health Nurs; 2008 Dec; 15(10):792-9. PubMed ID: 19012670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in the design and conduct of controlled clinical effectiveness trials in schizophrenia.
    Rosenheck RA; Krystal JH; Lew R; Barnett PG; Thwin SS; Fiore L; Valley D; Huang GD; Neal C; Vertrees JE; Liang MH;
    Clin Trials; 2011 Apr; 8(2):196-204. PubMed ID: 21270143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecule of the month. Paliperidone.
    Drug News Perspect; 2007 Jun; 20(5):333. PubMed ID: 17878961
    [No Abstract]   [Full Text] [Related]  

  • 20. Paliperidone ER versus risperidone for neurocognitive function in patients with schizophrenia: a randomized, open-label, controlled trial.
    Kim SW; Chung YC; Lee YH; Lee JH; Kim SY; Bae KY; Kim JM; Shin IS; Yoon JS
    Int Clin Psychopharmacol; 2012 Sep; 27(5):267-74. PubMed ID: 22809972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.